Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.
about
Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's diseaseBiomaterials for the Treatment of Alzheimer's DiseaseThe role of heat shock protein 70 in the protective effect of YC-1 on β-amyloid-induced toxicity in differentiated PC12 cells.Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's diseaseNeurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.Tau protein modifications and interactions: their role in function and dysfunction.Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.Determination of kinetic parameters and structure-activity relationships of ginsenosides as inhibitors of cyclin-dependent kinase 5/p25 using ultra-pressure liquid chromatography with triple quadrupole tandem mass spectrometry.Delphinidin ameliorates beta-amyloid-induced neurotoxicity by inhibiting calcium influx and tau hyperphosphorylation.Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.Selenium and Zinc against Aβ25-35-Induced Cytotoxicity and Tau Phosphorylation in PC12 Cells and Inhibits γ-cleavage of APP.Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.Human lysozyme inhibits the in vitro aggregation of Aβ peptides, which in vivo are associated with Alzheimer's disease.The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification
P2860
Q24302457-FD3FC898-E9A4-469C-A959-D1D6ACE9CAF6Q26744462-DBC13382-6EB0-4BAF-889A-468016D0F2B3Q34902456-E7ACDCF2-9CA3-47EB-B3E3-D5D960A44B3BQ36187149-C08EC13C-9A61-45D2-82BC-EA9C331F7971Q36804007-8BDE1083-9856-4A51-AF96-076DE3ACB390Q36865663-A75082FB-BC5A-4A53-A4D2-1B245905DA88Q37684106-18BEC4F8-371E-4E9F-9BCE-22746D9460BDQ39005823-F1B8126C-5A17-435E-AB87-C0F63FEE8B6EQ43868561-07EFE7D2-7AF5-4CF6-ABF3-6F2B992ACF72Q45936494-55ECBF5F-FA51-4E08-9CE5-CDC89DD3A21BQ46500132-8FB225E1-14D9-4202-B6F5-2C7660236C5AQ47590565-A0BC6397-A401-40B6-BD36-3A21CB274DC5Q48273890-408B219D-2421-44E2-B4CC-8B0D247D93F6Q50909964-4EF16708-C19B-45F6-888A-EF9D723D5BF2Q51026158-D847255D-28D9-4405-820D-E7816B746126Q58800414-BF1EEAB6-1186-4BCE-A340-2B69BF6135F5
P2860
Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Direct interaction of soluble ...... tion by tau protein kinase II.
@en
type
label
Direct interaction of soluble ...... tion by tau protein kinase II.
@en
prefLabel
Direct interaction of soluble ...... tion by tau protein kinase II.
@en
P2093
P2860
P1433
P1476
Direct interaction of soluble ...... ation by tau protein kinase II
@en
P2093
Adele M Pauley
David B Evans
Kenneth B Rank
Keshab Bhattacharya
Satish K Sharma
Timothy J Fleck
Zhigang Wang
P2860
P304
P356
10.1016/S0014-5793(02)02376-1
P407
P577
2002-03-01T00:00:00Z